Investor Toolbox
Listen to Call
Recording not yet available.
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
BIIB Coverage
Event
Biogen Inc (BIIB) Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
Mar 29, 2026
Event
Biogen Inc (BIIB) Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting
Mar 19, 2026
Event
Biogen Inc (BIIB) Sec Form 8K
Mar 12, 2026
News
Biogen Shares Rise on Q4 Earnings Beat Despite Lower Revenue Outlook
Feb 6, 2026
News
Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7%
Feb 6, 2026
Transcript
Biogen Inc (BIIB) Q4 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Biogen Inc (BIIB) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Biogen Inc (BIIB) Q3 2025 Earnings Call Transcript
Jan 22, 2026